TRAW icon

Traws Pharma
TRAW

Overview Fund Trends Analyst Outlook Journalist POV

19 hedge funds and large institutions have $10.2M invested in Traws Pharma in 2024 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding: →

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

3.31% more ownership

Funds ownership: 35.32% → 38.63% (+3.3%)

53% less call options, than puts

Call options by funds: $178K | Put options by funds: $376K

Holders
19
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$178K
Puts
$376K
Net Calls
Net Calls Change

Top Buyers

1
+$1.46M
2
+$1.04M
3
+$875K
4
VPC
Vestal Point Capital
New York
+$666K
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$185K

Top Sellers

1
-$121K
2
-$18.3K
3
-$2.23K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$5.38M
2
$1.46M
3
$1.04M
4
$875K
5
$666K
6
$185K
7
$140K
8
$117K
9
$108K
10
$89.3K
11
$88.9K
12
$88.4K
13
$10.3K
14
$7.02K
15
$1.82K
16
$1.38K
17
$675
18
$18
19
$7
20
–